| Current status of endoluminal grafting for exclusion of abdominal aortic aneurysms. The beauty and the beast. | |
| | |
MedLine Citation:
|
PMID: 9566057 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The exclusion of abdominal aortic aneurysms with endoluminal grafts has generated a great deal of interest since the early 1990s, and many centers are currently evaluating the procedure and comparing it to classic surgical exclusion. Although endoluminal grafting procedures show promise, development and clinical testing of devices is a time-consuming process that is influenced greatly by the regulatory climate in the country where the clinical trials take place. Nevertheless, a number of devices are currently under study, and the advantages of 2nd- and 3rd-generation technology are reflected in reduced rates of complications such as endoleaks and thrombosis. Further study will be required to perfect these devices and observe their long-term success in the exclusion of abdominal aortic aneurysms. |
| | |
Authors:
|
E B Diethrich |
Related Documents
:
|
8029397 - High-attenuating crescent in abdominal aortic aneurysm wall at ct: a sign of acute or i... 17888497 - Arterial aneurysms in wegener's granulomatosis: case report and literature review. 8010207 - Ct of abdominal aortic aneurysms. 9600287 - Incidence of abdominal wall hernia in aortic surgery. 18308867 - Determinants of the degree of functional aortic regurgitation in patients with anatomic... 22360897 - Left atrial appendage aneurysm with paroxysmal atrial fibrillation. |
Publication Detail:
|
Type: Comparative Study; Journal Article; Review |
Journal Detail:
|
Title: Texas Heart Institute journal / from the Texas Heart Institute of St. Luke's Episcopal Hospital, Texas Children's Hospital Volume: 25 ISSN: 0730-2347 ISO Abbreviation: Tex Heart Inst J Publication Date: 1998 |
Date Detail:
|
Created Date: 1998-06-16 Completed Date: 1998-06-16 Revised Date: 2009-11-18 |
Medline Journal Info:
|
Nlm Unique ID: 8214622 Medline TA: Tex Heart Inst J Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 10-6 Citation Subset: IM |
Affiliation:
|
Arizona Heart Institute, Phoenix 85006, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aortic Aneurysm, Abdominal
/
mortality,
surgery* Biocompatible Materials* Blood Vessel Prosthesis* Blood Vessel Prosthesis Implantation / instrumentation*, trends Humans Prosthesis Design Randomized Controlled Trials as Topic Survival Rate United States United States Food and Drug Administration |
| Chemical | |
Reg. No./Substance:
|
0/Biocompatible Materials |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Carotid angioplasty and stenting. Will they match the gold standard?
Next Document: Evolution of complete arterial grafting. For coronary artery disease.